Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with both episodic and chronic migraine.

If you identify as a "just in case" kind of packer, take a look at some of these handy finds. View Entire Post › ...